Cas:2095-06-9 n n-diglycidylaniline manufacturer & supplier

Chemical Name:n n-diglycidylaniline

CAS.NO:2095-06-9

Synonyms:Diglycidylaniline;N,N-bis-oxiranylmethyl-aniline;N,N-Bisglycidylaniline;n,n-diglycidylanilin;N,N-Diglycidylaniline;N,N-Bis-oxiranylmethyl-anilin;n-n-diglycidylphenylamine;N,N-Diglycidylbenzenamine;Phenyldiglycidylamine

Molecular Formula:C₁₂H₁₅NO₂

Molecular Weight:205.25300

HS Code:2921420090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:336.9ºC at 760mmHg

Density:1.221g/cm3

Index of Refraction:n20/D 1.571(lit.)

PSA:28.30000

Exact Mass:205.11000

LogP:1.29060

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like Diglycidylaniline chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Phenyldiglycidylamine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,N,N-bis-oxiranylmethyl-aniline Use and application,n,n-diglycidylanilin technical grade,usp/ep/jp grade.

Related News: CMO services mainly involve four stages: pre-clinical research, clinical trials, sales of patented drugs after listing, and sales of original drug products after patents expire. Its advantages are: lower cost, guaranteed quality, good capacity flexibility, and favorable process Promotion. n n-diglycidylaniline manufacturer Lilly did show much more conclusively that donanemab, which zeroes in on amyloid plaques, does reduce levels of the aggregates of misfolded proteins in the brain. This is what Biogen also showed with Aduhelm, and it turned out this week to be enough for a full FDA approval, hence the stock bump for Lilly. n n-diglycidylaniline supplier Lilly did show much more conclusively that donanemab, which zeroes in on amyloid plaques, does reduce levels of the aggregates of misfolded proteins in the brain. This is what Biogen also showed with Aduhelm, and it turned out this week to be enough for a full FDA approval, hence the stock bump for Lilly. n n-diglycidylaniline vendor By recapitulating the tumor microenvironment and using a live-cell, function-first approach, Resonant��s platform generates therapeutic candidates that would not be discovered by other methods with unprecedented speed. n n-diglycidylaniline factory ��No two studies are the same, and each carries its own unique risks and presents individual challenges, but the aim of CTSuccess is to use the experience we have as a company in supplying materials for thousands of trials to identify the characteristics of a project upfront and highlight potential risk factors that may arise,�� said Kristen Devito, Global Director, Catalent Clinical Supply Services.